Hereford and Worcester Sub Regional Trainers’ Workshop The Holiday Inn, Kidderminster Road Bromsgrove, B61 9AB 9th November 2017 Dr Richard Roope RCGP and Cancer Research UK Cancer Clinical Champion Senior Clinical Advisor Cancer Research UK
Trainers’ Workshop Earlier Diagnosis of Cancer
Earlier Diagnosis of Cancer Trainers’ Workshop Earlier Diagnosis of Cancer Cancer: why all the interest? Why is it important? How have we done? How could we do even better?
Trainers’ Workshop Cancer: why all the interest?
Cancer: why all the interest? Trainers’ Workshop Cancer: why all the interest? Causes of death <75 1 Circulatory Disease Cancer Liver Respiratory Other 2 Cancer Other Circulatory Disease Liver Respiratory 3 Circulatory Disease Cancer Respiratory Liver Other 4 Cancer Circulatory Disease Other Respiratory Liver
Cancer: why all the interest? Trainers’ Workshop Cancer: why all the interest? Causes of death <75 1 Circulatory Disease Cancer Liver Respiratory Other 2 Cancer Other Circulatory Disease Liver Respiratory 3 Circulatory Disease Cancer Respiratory Liver Other 4 Cancer Circulatory Disease Other Respiratory Liver Which do you think is the correct column? (high to low)
Cancer: why all the interest? Trainers’ Workshop Cancer: why all the interest? Causes of death <75 1 Circulatory Disease Cancer Liver Respiratory Other 2 Cancer Other Circulatory Disease Liver Respiratory 3 Circulatory Disease Cancer Respiratory Liver Other 4 Cancer Circulatory Disease Other Respiratory Liver
Cancer: why all the interest? Trainers’ Workshop Cancer: why all the interest? https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/307703/LW4L.pdf (last accessed 17.6.17)
Cancer: why all the interest? Trainers’ Workshop Cancer: why all the interest? 37% https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/307703/LW4L.pdf (last accessed 17.6.17)
Cancer: why all the interest? Trainers’ Workshop Cancer: why all the interest? https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/307703/LW4L.pdf (last accessed 17.6.17)
Trainers’ Workshop Cancer – why is it important? The Future:
Trainers’ Workshop Cancer – why is it important?
Trainers’ Workshop The perfect storm:
Trainers’ Workshop The perfect storm:
Trainers’ Workshop The Scale of the Challenge: The perfect storm…
Trainers’ Workshop The Scale of the Challenge: The perfect storm… Aging population
Trainers’ Workshop Aging Population
Trainers’ Workshop Aging Population
Trainers’ Workshop Aging Population - Centenarians 2013 2062 X Male 2,242 50,000 22.3 Female 12,328 80,000 6.5 TOTAL 14,750 130,000 8.8 http://www.ons.gov.uk/ons/rel/lifetables/historic-and-projected-data-from-the-period-and-cohort-life-tables/2012-based/info-surviving-to-age-100.html last accessed 3.11.17 http://www.ons.gov.uk/peoplepopulationandcommunity/birthsdeathsandmarriages/ageing/bulletins/estimatesoftheveryoldincludingcentenarians/2002to2015 last accessed 3.11.17
Trainers’ Workshop The Scale of the Challenge: The perfect storm… Aging population Lifestyles less healthy: Smoking Diet Alcohol Exercise Sun exposure
Trainers’ Workshop The Scale of the Challenge: The perfect storm… Aging population Lifestyles less healthy: Smoking Diet Alcohol Exercise Sun exposure Increasing survival
Trainers’ Workshop The perfect storm: Numbers of cancers 2013 2030 % increase UK 352,000 424,789 20.7% Global 14.1 million 23.6 million 67.4% http://globocan.iarc.fr/old/burden.asp?selection_pop=206826&Text-p=United+Kingdom&selection_cancer=290&Text-c=All+cancers+excl.+non-melanoma+skin+cancer&pYear=18&type=0&window=1&submit=%C2%A0Execute https://publications.cancerresearchuk.org/downloads/product/CS_REPORT_WORLD.pdf
Trainers’ Workshop The Scale of the Challenge: By the end of 2016, there were 1,000 people in the UK being diagnosed with cancer every day Mistry, M., et al., Cancer incidence in the United Kingdom: projections to the year 2030. Br J Cancer, 2011. 105: p. 17951803.
Cancer: why all the interest? Trainers’ Workshop Cancer: why all the interest? 1 in 2 people will be diagnosed with one or more cancers in their lifetime
Lifetime risk of cancer: Trainers’ Workshop Lifetime risk of cancer: http://www.cancerresearchuk.org/cancer-info/cancerstats/incidence/risk/
Cancer: why all the interest? Trainers’ Workshop Cancer: why all the interest? 1 in 2 people will be diagnosed with one or more cancers in their lifetime 10 year survival has improved to reach 50%
Cancer: why all the interest? Trainers’ Workshop Cancer: why all the interest? 1 in 2 people will be diagnosed with one or more cancers in their lifetime 10 year survival has improved to reach 50% www.cancerresearchuk.org/health-professional/cancer-statistics/survival/all-cancers-combined#heading-One – last accessed 3.11.17
Cancer: why all the interest? Trainers’ Workshop Cancer: why all the interest? 1 in 2 people will be diagnosed with one or more cancers in their lifetime 10 year survival has improved to reach 50%, but… Cancer survival in the UK still lags behind comparable health economies
Trainers’ Workshop Hasn’t cancer had its turn?
Hasn’t cancer had its turn? Trainers’ Workshop Hasn’t cancer had its turn? Cancer receives what proportion of NHS spend? 2.4% 5.4% 8.4% 11.4% 14.4% Discuss with your neighbour….
Trainers’ Workshop Hasn’t cancer had its turn? Total NHS spend in 2012/3: £125,700,000,000
Trainers’ Workshop Hasn’t cancer had its turn? Total NHS spend in 2012/3: £125,700,000,000 Total NHS spend in 2012/3: £2008 per head
Trainers’ Workshop Hasn’t cancer had its turn? Total NHS spend in 2012/3: £125,700,000,000 Total NHS spend in 2012/3: £2008 per head Total NHS spend cancer care: £109 per head
Hasn’t cancer had its turn? Trainers’ Workshop Hasn’t cancer had its turn? Total NHS spend in 2012/3: £125,700,000,000 Total NHS spend in 2012/3: £2008 per head Total NHS spend cancer care: £109 per head Just 5.4% of NHS spend http://www.nuffieldtrust.org.uk/nhs-numbers-0 last accessed 1.3.17
Hasn’t cancer had its turn? Trainers’ Workshop Hasn’t cancer had its turn? Cancer receives what proportion of NHS spend? 2.4% 5.4% 8.4% 11.4% 14.4%
Trainers’ Workshop Why is early diagnosis important?
Why is early diagnosis important? Trainers’ Workshop Why is early diagnosis important? http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/breast-cancer/survival#heading-Three (last accessed 3.11.17)
Trainers’ Workshop Why is early diagnosis important?
Why is early diagnosis important? Trainers’ Workshop Why is early diagnosis important? http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/prostate-cancer/survival#heading-Two (last accessed 3.11.17)
Trainers’ Workshop Why is early diagnosis important?
Why is early diagnosis important? Trainers’ Workshop Why is early diagnosis important? http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/bowel-cancer/survival#heading-Three (last accessed 3.11.17)
Trainers’ Workshop Why is early diagnosis important?
Why is early diagnosis important? Trainers’ Workshop Why is early diagnosis important? http://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/lung-cancer/survival#heading-Three (last accessed 3.11.17)
Trainers’ Workshop Why is early diagnosis important?
Why is early diagnosis important? Trainers’ Workshop Why is early diagnosis important? All Cancers www.cancerresearchuk.org/health-professional/cancer-statistics/incidence/all-cancers-combined#heading-Two (last accessed 3.11.17)
Why is early diagnosis important? Trainers’ Workshop Why is early diagnosis important? All Cancers Stage Shift www.cancerresearchuk.org/health-professional/cancer-statistics/incidence/all-cancers-combined#heading-Two (last accessed 3.11.17)
Trainers’ Workshop Minimum increased 5 year survival with 10% increase in stages 1 & 2 Colorectal 4.00% Ovary Breast 3.80% Endometrium 3.70% Prostate 2.40% Melanoma 2.30% Lung 2.00% Kidney Bladder 1.30% NHL 0.20% https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/388160/fourth_annual_report.pdf (last accessed 3.11.17)
Trainers’ Workshop Why is early diagnosis important? Cost
Why is early diagnosis important? Trainers’ Workshop Why is early diagnosis important? http://www.cancerresearchuk.org/sites/default/files/saving_lives_averting_costs.pdf
Why is early diagnosis important? Trainers’ Workshop Why is early diagnosis important? ↓72.8% ↓62.7% ↓64.9% ↓38.9% http://www.cancerresearchuk.org/sites/default/files/saving_lives_averting_costs.pdf
Trainers’ Workshop How have we done?
Cancer – where have we come from? January 2011 - Improving Outcomes: A Strategy for Cancer
Trainers’ Workshop How have we done? Avoidable deaths pa if survival in England matched the best in Europe Breast ~2000 Myeloma 250 Colorectal ~1700 Endometrial 250 Lung ~1300 Leukaemia 240 Oesophagogastric 950 Brain 225 Kidney ~700 Melanoma 190 Ovary ~500 Cervix 180 NHL/HD 370 Oral/Larynx 170 Bladder 290 Pancreas 75
Trainers’ Workshop How have we done?
Trainers’ Workshop How have we done?
Trainers’ Workshop Research stream Primary Care Engagement How have we done? Research stream Primary Care Engagement Input to Cancer Network and SCNs RCGP Education Events etc
Trainers’ Workshop How have we done?
Trainers’ Workshop How have we done? https://fingertips.phe.org.uk/profile/cancerservices
Trainers’ Workshop How have we done? https://fingertips.phe.org.uk/profile/cancerservices (last accessed 21.1.17)
Trainers’ Workshop Emergency Presentations of Cancer
Trainers’ Workshop Emergency Presentations of Cancer
Trainers’ Workshop How have we done? http://www.ncin.org.uk/publications/routes_to_diagnosis (last accessed 7.11.17)
Trainers’ Workshop How have we done? ↑66.0% ↓1.2% ↑77.8% http://www.ncin.org.uk/publications/routes_to_diagnosis (last accessed 7.11.17)
Trainers’ Workshop Variation: NHS Herefordshire CCG, South Worcestershire CCG NHS Redditch and Bromsgrove CCG http://lci.cancertoolkit.co.uk/Survival (last accessed 5.3.17)
Trainers’ Workshop Englandion NHS Newcastle and North East NHS South Worcestershire NHS Redditch and Bromsgrove http://lci.cancertoolkit.co.uk/Survival (last accessed 21.1.17)
Trainers’ Workshop PHE Press release 16.9.15: “Cancers are being diagnosed earlier in England” https://www.gov.uk/government/news/cancers-are-being-diagnosed-earlier-in-england (last accessed 21.1.17)
Trainers’ Workshop However compared to Europe?
Trainers’ Workshop However compared to Europe? http://scienceblog.cancerresearchuk.org/2015/08/05/cancer-survival-in-england-is-improving-but-still-lagging-behind-similar-countries/
Trainers’ Workshop However compared to Europe? http://scienceblog.cancerresearchuk.org/2015/08/05/cancer-survival-in-england-is-improving-but-still-lagging-behind-similar-countries/
Trainers’ Workshop Why do we lag behind other Health Systems?
Trainers’ Workshop Why do we lag behind other Health Systems? International Cancer Benchmarking Partnership As gatekeepers – the gate needs to be wider Outcomes closely linked to “readiness to act” Patients fear wasting GP time Differences in cancer awareness and beliefs between Australia, Canada, Denmark, Norway, Sweden and the UK (the International Cancer Benchmarking Partnership): do they contribute to differences in cancer survival? British Journal of Cancer (2013) 108, 292–300. doi:10.1038/bjc.2012.542 (last accessed 3.11.17)
Trainers’ Workshop Gate openers…
Trainers’ Workshop
Trainers’ Workshop
Trainers’ Workshop Cancer Strategy 2015-2020 has three core aims: Save thousands more lives Transform patient experience and quality of life Invest now to save later www.cancerresearchuk.org/sites/default/files/achieving_world-class_cancer_outcomes_-_a_strategy_for_england_2015-2020.pdf (last accessed 3.11.17)
Trainers’ Workshop Cancer Strategy 2015-2020 has three core aims: 1. Save more lives Early Diagnosis
Trainers’ Workshop Cancer Strategy 2015-2020 has three core aims: 1. Save more lives Early Diagnosis Enhance screening uptake Implement NICE Guidance (NG12) Invest in diagnostic capacity Direct access to diagnostic capacity 28 days to diagnosis (to replace 2WW) Education – Undergraduate, postgraduate, CPD
Trainers’ Workshop Cancer Strategy 2015-2020 has three core aims: 1. Save more lives Early Diagnosis Enhance screening uptake Implement NICE Guidance (NG12) Invest in diagnostic capacity Direct access to diagnostic capacity 28 days to diagnosis (to replace 2WW) Education – Undergraduate, postgraduate, CPD
Trainers’ Workshop Cancer Strategy 2015-2020 has three core aims: Save thousands more lives Transform patient experience and quality of life
Trainers’ Workshop Cancer Strategy 2015-2020 has three core aims: Save thousands more lives Transform patient experience and quality of life Early diagnosis determines experience throughout whole cancer pathway Mendonca SC, Abel GA, Saunders CL, Wardle J, Lyratzopoulos G. Pre-referral general practitioner consultations and subsequent experience of cancer care: evidence from the English Cancer Patient Experience Survey. European Journal of Cancer Care. 2015.
Trainers’ Workshop Cancer Strategy 2015-2020 has three core aims: Save thousands more lives Transform patient experience and quality of life Invest now to save later
Trainers’ Workshop Cancer Strategy 2015-2020 has three core aims: Save thousands more lives Transform patient experience and quality of life Invest now to save later Investing in early diagnosis will save money…
Trainers’ Workshop
Trainers’ Workshop Prevention Tobacco Food Immunisations Exercise Environment Early detection Awareness Health care seeking Screening Access Diagnosis Investigations Access Technology Decision support Treatment Surgery Chemotherapy Radiotherapy Comorbidity Psychology Survivorship Follow-up Late effects Rehabilitation Health promotion End of life Basic palliation Specialised Social Bereavement
Trainers’ Workshop Prevention Tobacco Food Immunisations Exercise Environment Early detection Awareness Health care seeking Screening Access Diagnosis Investigations Access Technology Decision support Treatment Surgery Chemotherapy Radiotherapy Comorbidity Psychology Survivorship Follow-up Late effects Rehabilitation Health promotion End of life Basic palliation Specialised Social Bereavement
Trainers’ Workshop Value in investing in early diagnosis:
Trainers’ Workshop Value in investing in early diagnosis: Why? To address our lowly cancer outcomes rank How? To lower threshold/readiness to refer with consistency: Right patient, right place, right time When? Now
Trainers’ Workshop How? Bowel Cancer – survival improving: Start with some background. Cancer strategy for England in July 2015, developed by an Independent Cancer Taskforce (on which RCGP was represented), presents a vision for cancer control in the next five years. These are strategies that lay out a vision and plan for the future: a framework to guide our thinking. But what do these strategies mean in practice? And more specifically what does this mean for primary care? Let’s consider the scale of the challenge first
Trainers’ Workshop Importance of bowel screening
Trainers’ Workshop Importance of bowel screening http://www.ncin.org.uk/publications/routes_to_diagnosis (accessed 3.11.17)
Trainers’ Workshop Importance of bowel screening http://www.ncin.org.uk/publications/routes_to_diagnosis (accessed 3.11.17)
Trainers’ Workshop Importance of bowel screening Screening presentations – hugely better outcomes Should be area of priority
Trainers’ Workshop Importance of bowel screening Role of GP Endorsement
Trainers’ Workshop Importance of bowel screening Role of GP Endorsement – increases uptake by 8%1 Br J Cancer. 2017 Jun 6;116(12):1551-1557. doi: 10.1038/bjc.2017.129. Epub 2017 May 18.
Trainers’ Workshop Importance of bowel screening Role of GP Endorsement – increases uptake by 8%1 Rolled out by some Screening Hubs
Trainers’ Workshop NG12 - Suspected cancer: recognition and referral
Trainers’ Workshop NG12 - Suspected cancer: recognition and referral Recommendation 16: We recommend the following to take forward the new NICE guidelines: • NICE should work with organisations such as Cancer Research UK, the Royal College of GPs and Macmillan Cancer Support to disseminate and communicate the new referral guidelines to GP practices as quickly as possible.
Trainers’ Workshop NICE Guidance (NG12) Aim The aim of the guidelines is to improve cancer diagnosis: The timeliness The quality The consistency Start with some background. Cancer strategy for England in July 2015, developed by an Independent Cancer Taskforce (on which RCGP was represented), presents a vision for cancer control in the next five years. These are strategies that lay out a vision and plan for the future: a framework to guide our thinking. But what do these strategies mean in practice? And more specifically what does this mean for primary care? Let’s consider the scale of the challenge first
Trainers’ Workshop NICE Guidance (NG12) Implementation “While guidelines assist the practice of healthcare professionals, they do not replace their knowledge and skills.” Start with some background. Cancer strategy for England in July 2015, developed by an Independent Cancer Taskforce (on which RCGP was represented), presents a vision for cancer control in the next five years. These are strategies that lay out a vision and plan for the future: a framework to guide our thinking. But what do these strategies mean in practice? And more specifically what does this mean for primary care? Let’s consider the scale of the challenge first
Trainers’ Workshop NICE Guidance (NG12) Implementation “For all clinical scenarios it is assumed that the health professional will have a discussion with the patient about the risks and benefits of intervention, enabling the patient to exercise a fully informed decision.” Start with some background. Cancer strategy for England in July 2015, developed by an Independent Cancer Taskforce (on which RCGP was represented), presents a vision for cancer control in the next five years. These are strategies that lay out a vision and plan for the future: a framework to guide our thinking. But what do these strategies mean in practice? And more specifically what does this mean for primary care? Let’s consider the scale of the challenge first
Trainers’ Workshop NICE Guidance (NG12) Implementation The guideline focuses on those areas of clinical practice: That are known to be controversial or uncertain Where there is identifiable practice variation Where there is lack of high quality evidence Where NICE guidelines are likely to have the most impact. Start with some background. Cancer strategy for England in July 2015, developed by an Independent Cancer Taskforce (on which RCGP was represented), presents a vision for cancer control in the next five years. These are strategies that lay out a vision and plan for the future: a framework to guide our thinking. But what do these strategies mean in practice? And more specifically what does this mean for primary care? Let’s consider the scale of the challenge first
Trainers’ Workshop NICE Guidance (NG12) Implementation It is assumed that: an appropriate history and physical examination are undertaken urinalysis is undertaken where appropriate simple blood tests (Fbc, biochemistry and inflammatory markers) are done Start with some background. Cancer strategy for England in July 2015, developed by an Independent Cancer Taskforce (on which RCGP was represented), presents a vision for cancer control in the next five years. These are strategies that lay out a vision and plan for the future: a framework to guide our thinking. But what do these strategies mean in practice? And more specifically what does this mean for primary care? Let’s consider the scale of the challenge first
Trainers’ Workshop NICE Guidance (NG12) What is new? This is the first guidance that uses primary care evidence, which is available for the first time Adds symptom pathways for the first time Uses the same referral thresholds for all cancers Start with some background. Cancer strategy for England in July 2015, developed by an Independent Cancer Taskforce (on which RCGP was represented), presents a vision for cancer control in the next five years. These are strategies that lay out a vision and plan for the future: a framework to guide our thinking. But what do these strategies mean in practice? And more specifically what does this mean for primary care? Let’s consider the scale of the challenge first
Trainers’ Workshop NICE Guidance (NG12) What is new? This is the first guidance that uses primary care evidence, which is available for the first time Adds symptom pathways for the first time Uses the same minimum referral thresholds for all cancers (PPV 3%) Start with some background. Cancer strategy for England in July 2015, developed by an Independent Cancer Taskforce (on which RCGP was represented), presents a vision for cancer control in the next five years. These are strategies that lay out a vision and plan for the future: a framework to guide our thinking. But what do these strategies mean in practice? And more specifically what does this mean for primary care? Let’s consider the scale of the challenge first
Trainers’ Workshop NICE Guidance (NG12) What is new? (General) Many – being symptom centred and using 3% PPV, the ages vary (range 30-60) Some criteria have been dropped (no evidence to support them) Timeline specifics have gone – replaced with “recurrent” or “persistent”. Start with some background. Cancer strategy for England in July 2015, developed by an Independent Cancer Taskforce (on which RCGP was represented), presents a vision for cancer control in the next five years. These are strategies that lay out a vision and plan for the future: a framework to guide our thinking. But what do these strategies mean in practice? And more specifically what does this mean for primary care? Let’s consider the scale of the challenge first
Trainers’ Workshop NICE Guidance (NG12) What is new? (Specifics) Relevance of ↑ Platelet count Start with some background. Cancer strategy for England in July 2015, developed by an Independent Cancer Taskforce (on which RCGP was represented), presents a vision for cancer control in the next five years. These are strategies that lay out a vision and plan for the future: a framework to guide our thinking. But what do these strategies mean in practice? And more specifically what does this mean for primary care? Let’s consider the scale of the challenge first
Trainers’ Workshop NICE Guidance (NG12) What is new? (Specifics) Relevance of ↑ Platelet count Start with some background. Cancer strategy for England in July 2015, developed by an Independent Cancer Taskforce (on which RCGP was represented), presents a vision for cancer control in the next five years. These are strategies that lay out a vision and plan for the future: a framework to guide our thinking. But what do these strategies mean in practice? And more specifically what does this mean for primary care? Let’s consider the scale of the challenge first Br J Gen Pract 2017; 67 (659): e405-e413.
Trainers’ Workshop NICE Guidance (NG12) What is new? (Specifics) Relevance of ↑ Platelet count 7.8% of patients (11.6% of males, 6.2% of females) will have a 1 year cancer incidence: Start with some background. Cancer strategy for England in July 2015, developed by an Independent Cancer Taskforce (on which RCGP was represented), presents a vision for cancer control in the next five years. These are strategies that lay out a vision and plan for the future: a framework to guide our thinking. But what do these strategies mean in practice? And more specifically what does this mean for primary care? Let’s consider the scale of the challenge first Br J Gen Pract 2017; 67 (659): e405-e413.
Trainers’ Workshop NICE Guidance (NG12) What is new? (Specifics) Relevance of ↑ Platelet count 7.8% of patients (11.6% of males, 6.2% of females) will have a 1 year cancer incidence: If a second blood test shows platelet count to be the same or higher: 18.1% of males and 10.1% of females will have a 1 year cancer incidence Start with some background. Cancer strategy for England in July 2015, developed by an Independent Cancer Taskforce (on which RCGP was represented), presents a vision for cancer control in the next five years. These are strategies that lay out a vision and plan for the future: a framework to guide our thinking. But what do these strategies mean in practice? And more specifically what does this mean for primary care? Let’s consider the scale of the challenge first Br J Gen Pract 2017; 67 (659): e405-e413.
Trainers’ Workshop NICE Guidance (NG12) What is new? (Specifics) Relevance of ↑ Platelet count Seen in cancers of: Lung Lower GI Prostate Breast OG Ovarian Start with some background. Cancer strategy for England in July 2015, developed by an Independent Cancer Taskforce (on which RCGP was represented), presents a vision for cancer control in the next five years. These are strategies that lay out a vision and plan for the future: a framework to guide our thinking. But what do these strategies mean in practice? And more specifically what does this mean for primary care? Let’s consider the scale of the challenge first Br J Gen Pract 2017; 67 (659): e405-e413.
Trainers’ Workshop NICE Guidance (NG12) What is new? (Specifics - examples) 2ww lung - Haemoptysis only in 40+ Mesothelioma now covered Lower GI – high risk groups (eg ulcerative colitis) not mentioned. 2ww breast: unexplained axillary lump Haematuria and ↑platelets →gynae ultrasound Dermatoscopy suggestive of melanoma → 2ww dermatology Start with some background. Cancer strategy for England in July 2015, developed by an Independent Cancer Taskforce (on which RCGP was represented), presents a vision for cancer control in the next five years. These are strategies that lay out a vision and plan for the future: a framework to guide our thinking. But what do these strategies mean in practice? And more specifically what does this mean for primary care? Let’s consider the scale of the challenge first
Trainers’ Workshop NICE Guidance (NG12) What is new? (Specifics - examples) Persistent bone pain, unexplained fracture: do Fbc + ESR 60+ with hypercalcaemia/↓wbc: electrophoresis and BJP within 48h Palpable abdominal mass <16 (used to be under 1y) Start with some background. Cancer strategy for England in July 2015, developed by an Independent Cancer Taskforce (on which RCGP was represented), presents a vision for cancer control in the next five years. These are strategies that lay out a vision and plan for the future: a framework to guide our thinking. But what do these strategies mean in practice? And more specifically what does this mean for primary care? Let’s consider the scale of the challenge first
Trainers’ Workshop Safety netting.
Trainers’ Workshop Safety netting. More in afternoon workshop
Trainers’ Workshop Value in investing in early diagnosis: Results?
Trainers’ Workshop Value in investing in early diagnosis: Results? Better medicine – earlier diagnosis (not just of cancer) Fewer consultations Better outcomes Less complaints/litigation Less £££
Trainers’ Workshop Key to cancer
Trainers’ Workshop Key to cancer Education
Trainers’ Workshop Key to cancer Education – public Education – patients Education – profession
Trainers’ Workshop Key to cancer Education – public Education – patients Education – profession Education – policy makers
Trainers’ Workshop Key to cancer Education – public Education – patients Education – profession Education – policy makers Education – politicians
Earlier Diagnosis of Cancer Trainers’ Workshop Earlier Diagnosis of Cancer Cancer: why all the interest? Why is it important? How have we done? How could we do even better?
Trainers’ Workshop Insanity:
Trainers’ Workshop Insanity: doing the same thing over and over again and expecting different results
Trainers’ Workshop Insanity: doing the same thing over and over again and expecting different results Albert Einstein 1879-1955
Trainers’ Workshop The ones who are crazy enough to think they can change the world, are the ones who do.
Trainers’ Workshop The ones who are crazy enough to think they can change the world, are the ones who do. Steve Jobs 1955-2001
Trainers’ Workshop Our common goal?
Trainers’ Workshop Our common goal?
Trainers’ Workshop One person can make a difference, and everyone should try.
Trainers’ Workshop One person can make a difference, and everyone should try. John F Kennedy 1917-1963
Trainers’ Workshop Thank you
Trainers’ Workshop Any questions?